Page 36 - G43 ASSIGNMENT

So, what can we say to hypertensive patients who may be anxious about
taking anti-hypertensive medication and about their risks from infection
during the COVID-19 pandemic?

We should support all our hypertensive patients in continuing to strive for, and maintain, good blood
pressure control by continuing to take their medications as prescribed, and by endeavouring to follow
and maintain sensible lifestyle choices, including regular exercise [ 3 ].

Coronavirus vaccine

once the jab is injected into the body. Fever, hypertension , weakness, malaise, pain at the injection site
being some of the common ones.

The effect of interleukin storm on BP

• Interleukin-6 (IL-6) is the major proinflammatory cytokine
• It has been described to be associated with the hypertensive and atherosclerotic states
• The concentration of circulating IL-6 and adhesion molecules could be modified by decreasing blood
pressure in hypertensive states
• The treatment of high blood pressure lowers circulating IL-6 in young hypertensive patients.
References

1.
Global Burden of Disease 2015 Risk Factors Collaborators. Global, regional, and national comparative risk
assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–
2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388:1659–724.
2.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of
worldwide data. Lancet. 2005; 365:217–
3.
https://www.nhs.uk/conditions/coronavirus-covid-19/people-at-higher-risk/whos-at-higher-risk-from-
coronavirus/ NHS England 7/1/21; accessed 18 Jan 2021.
4.
https://www.researchgate.net/publication/7975420_Lowering_of_blood_pressure_leads_to_decreased_circu
lating_interleukin-6_in_hypertensive_subjects

36